DOI . ORG {}

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Doi.org Make Money
Keywords
Topics
Questions
Schema
External Links
Analytics And Tracking
Libraries
Hosting Providers
CDN Services

We began analyzing https://link.springer.com/article/10.1007/s11010-009-0219-x, but it redirected us to https://link.springer.com/article/10.1007/s11010-009-0219-x. The analysis below is for the second page.

Title[redir]:
Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart | Molecular and Cellular Biochemistry
Description:
Nitric oxide (NO) produced in the heart by nitric oxide synthase (NOS) is a highly reactive signaling molecule and an important modulator of myocardial function. NOS catalyzes the conversion of l-arginine to l-citrulline and NO but under particular circumstances reactive oxygen species (ROS) can be formed instead of NO (uncoupling). In the heart, three NOS isoforms are present: neuronal NOS (nNOS, NOS1) and endothelial NOS (eNOS, NOS3) are constitutively present enzymes in distinct subcellular locations within cardiomyocytes, whereas inducible NOS (iNOS, NOS2) is absent in the healthy heart, but its expression is induced by pro-inflammatory mediators. In the tissue, NO has two main effects: (i) NO stimulates the activity of guanylate cyclase, leading to cGMP generation and activation of protein kinase G, and (ii) NO nitrosylates tyrosine and thiol-groups of cysteine in proteins. Upon nitrosylation, proteins may change their properties. Changes in (i) NOS expression and activity, (ii) subcellular compartmentation of NOS activity, and (iii) the occurrence of uncoupling may lead to multiple NO-induced effects, some of which being particularly evident during myocardial overload as occurs during aortic constriction and myocardial infarction. Many of these NO-induced effects are considered to be cardioprotective but particularly if NOS becomes uncoupled, formation of ROS in combination with a low NO bioavailability predisposes for cardiac damage.

Matching Content Categories {📚}

Education
Health & Fitness
Fitness & Wellness

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We can't see how the site brings in money.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Doi.org might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

google, scholar, nitric, oxide, synthase, heart, cardiac, myocardial, res, failure, circ, endothelial, physiol, inducible, circulation, neuronal, cell, mice, nos, hypertrophy, ventricular, function, expression, protein, infarction, role, human, article, calcium, regulation, sci, remodeling, kinase, left, biol, usa, overexpression, hypertension, ryanodine, receptor, pharmacol, myocytes, mol, cardiol, cardiovasc, proc, natl, acad, failing, van,

Topics {✒️}

g-monomethyl-l-arginine xod inducible nitric-oxide synthase month download article/chapter cardiac excitation-contraction coupling cytokine-induced nitric oxide sarcoplasmic reticulum ca2+-atpase camp-dependent protein kinase nitric oxide regulates nitric oxide derived l-type calcium channels integrin stimulation-induced hypertrophy van der laarse cyclic gmp-dependent mechanism β-adrenergic receptor therapy fas-induced caspase denitrosylation arg-gly-asp motif end-stage heart failure nitric oxide/cgmp signaling neuronal nitric oxide nitric oxide synthase pressure overload-induced hypertrophy arginine-depleted cells leading reduced ischemia-reperfusion injury interleukin-1β-converting enzyme cardiac nitric oxide nitric oxide synthases reactive oxygen species peroxynitrite-induced myocardial injury nitric oxide signaling left ventricular function cardiac sarcoplasmic reticulum exogenous nitric oxide cardiac myocyte-specific expression β-adrenergic contractility peroxynitrite-mediated cellular injury myocardial oxygen consumption s-nitrosothiol conserved reactive nitrogen species nitric oxide production nitric oxide regulation von der leyen myofibillar creatine kinase severe cardiac dysfunction high-energy phosphates congestive heart failure privacy choices/manage cookies protein s-nitrosylation cellular biochemistry aims van faassen ee β-adrenergic hyporesponsiveness

Questions {❓}

Mannick JB, Schonhoff CM (2002) Nitrosylation: the next phosphorylation?
Martin SR, Emanuel K, Sears CE et al (2006) Are myocardial eNOS and nNOS involved in the β-adrenergic and muscarinic regulation of inotropy?
Nathan C (1997) Inducible nitric oxide synthase: what difference does it make?
Paulus WJ, Bronzwaer JG (2004) Nitric oxide’s role in the heart: control of beating or breathing?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart
         description:Nitric oxide (NO) produced in the heart by nitric oxide synthase (NOS) is a highly reactive signaling molecule and an important modulator of myocardial function. NOS catalyzes the conversion of l-arginine to l-citrulline and NO but under particular circumstances reactive oxygen species (ROS) can be formed instead of NO (uncoupling). In the heart, three NOS isoforms are present: neuronal NOS (nNOS, NOS1) and endothelial NOS (eNOS, NOS3) are constitutively present enzymes in distinct subcellular locations within cardiomyocytes, whereas inducible NOS (iNOS, NOS2) is absent in the healthy heart, but its expression is induced by pro-inflammatory mediators. In the tissue, NO has two main effects: (i) NO stimulates the activity of guanylate cyclase, leading to cGMP generation and activation of protein kinase G, and (ii) NO nitrosylates tyrosine and thiol-groups of cysteine in proteins. Upon nitrosylation, proteins may change their properties. Changes in (i) NOS expression and activity, (ii) subcellular compartmentation of NOS activity, and (iii) the occurrence of uncoupling may lead to multiple NO-induced effects, some of which being particularly evident during myocardial overload as occurs during aortic constriction and myocardial infarction. Many of these NO-induced effects are considered to be cardioprotective but particularly if NOS becomes uncoupled, formation of ROS in combination with a low NO bioavailability predisposes for cardiac damage.
         datePublished:2009-07-19T00:00:00Z
         dateModified:2009-07-19T00:00:00Z
         pageStart:191
         pageEnd:201
         sameAs:https://doi.org/10.1007/s11010-009-0219-x
         keywords:
            Nitric oxide
            Hypertrophy
            Nitric oxide synthase
            Heart failure
            Biochemistry
            general
            Cardiology
            Cancer Research
            Medical Biochemistry
         image:
         isPartOf:
            name:Molecular and Cellular Biochemistry
            issn:
               1573-4919
               0300-8177
            volumeNumber:333
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Soban Umar
               affiliation:
                     name:Leiden University Medical Center
                     address:
                        name:Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Arnoud van der Laarse
               affiliation:
                     name:Leiden University Medical Center
                     address:
                        name:Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart
      description:Nitric oxide (NO) produced in the heart by nitric oxide synthase (NOS) is a highly reactive signaling molecule and an important modulator of myocardial function. NOS catalyzes the conversion of l-arginine to l-citrulline and NO but under particular circumstances reactive oxygen species (ROS) can be formed instead of NO (uncoupling). In the heart, three NOS isoforms are present: neuronal NOS (nNOS, NOS1) and endothelial NOS (eNOS, NOS3) are constitutively present enzymes in distinct subcellular locations within cardiomyocytes, whereas inducible NOS (iNOS, NOS2) is absent in the healthy heart, but its expression is induced by pro-inflammatory mediators. In the tissue, NO has two main effects: (i) NO stimulates the activity of guanylate cyclase, leading to cGMP generation and activation of protein kinase G, and (ii) NO nitrosylates tyrosine and thiol-groups of cysteine in proteins. Upon nitrosylation, proteins may change their properties. Changes in (i) NOS expression and activity, (ii) subcellular compartmentation of NOS activity, and (iii) the occurrence of uncoupling may lead to multiple NO-induced effects, some of which being particularly evident during myocardial overload as occurs during aortic constriction and myocardial infarction. Many of these NO-induced effects are considered to be cardioprotective but particularly if NOS becomes uncoupled, formation of ROS in combination with a low NO bioavailability predisposes for cardiac damage.
      datePublished:2009-07-19T00:00:00Z
      dateModified:2009-07-19T00:00:00Z
      pageStart:191
      pageEnd:201
      sameAs:https://doi.org/10.1007/s11010-009-0219-x
      keywords:
         Nitric oxide
         Hypertrophy
         Nitric oxide synthase
         Heart failure
         Biochemistry
         general
         Cardiology
         Cancer Research
         Medical Biochemistry
      image:
      isPartOf:
         name:Molecular and Cellular Biochemistry
         issn:
            1573-4919
            0300-8177
         volumeNumber:333
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Soban Umar
            affiliation:
                  name:Leiden University Medical Center
                  address:
                     name:Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Arnoud van der Laarse
            affiliation:
                  name:Leiden University Medical Center
                  address:
                     name:Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Molecular and Cellular Biochemistry
      issn:
         1573-4919
         0300-8177
      volumeNumber:333
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Leiden University Medical Center
      address:
         name:Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
         type:PostalAddress
      name:Leiden University Medical Center
      address:
         name:Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Soban Umar
      affiliation:
            name:Leiden University Medical Center
            address:
               name:Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
               type:PostalAddress
            type:Organization
      name:Arnoud van der Laarse
      affiliation:
            name:Leiden University Medical Center
            address:
               name:Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
      name:Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(191)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

Emails and Hosting {✉️}

Mail Servers:

mx.zoho.eu
mx2.zoho.eu
mx3.zoho.eu

Name Servers:

josh.ns.cloudflare.com
zita.ns.cloudflare.com

CDN Services {📦}

Crossref

5.15s.